SAFETY AND EFFICACY OF THE “CARMEN” REGIMEN, A NEW DOSE‐DENSE SHORT‐TERM THERAPY IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA AND
            MYC
            REARRANGEMENT

A. J. M Ferreri; P Angelillo; F Erbella; C Liberatore; C Cattaneo; L Verga; A Lleshi; B Allione; F Facchetti; M Ponzoni; C Pagani; M Foppoli; L Pecciarini; M. C Sassone; E Flospergher; G Rossi; M Spina;  A. Re

doi:10.1002/hon.93_2880

SAFETY AND EFFICACY OF THE “CARMEN” REGIMEN, A NEW DOSE‐DENSE SHORT‐TERM THERAPY IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA AND MYC REARRANGEMENT

Hematological Oncology ◽

10.1002/hon.93_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

A. J. M Ferreri ◽

P Angelillo ◽

F Erbella ◽

C Liberatore ◽

C Cattaneo ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Term Therapy ◽

Short Term ◽

Safety And Efficacy ◽

Short Term Therapy ◽

Dose Dense ◽

Aggressive B Cell Lymphoma

Download Full-text

A dose‐dense short‐term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high‐risk Burkitt lymphoma or high‐grade B‐cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial

British Journal of Haematology ◽

10.1111/bjh.17188 ◽

2020 ◽

Vol 192 (1) ◽

pp. 119-128

Author(s):

Andrés J. M. Ferreri ◽

Chiara Cattaneo ◽

Arben Lleshi ◽

Luisa Verga ◽

Bernardino Allione ◽

...

Keyword(s):

Phase Ii Trial ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Term Therapy ◽

High Grade ◽

Short Term ◽

Immunodeficiency Virus ◽

Acquired Immunodeficiency ◽

Dose Dense ◽

Immunodeficiency Syndrome

Download Full-text

CD19/CD22 Dual-Targeted CAR T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: A Safety and Efficacy Study

Cancer Immunology Research ◽

10.1158/2326-6066.cir-20-0675 ◽

2021 ◽

pp. canimm.CIR-20-0675-A.2020

Author(s):

Guoqing Wei ◽

Yanlei Zhang ◽

Houli Zhao ◽

Yiyun Wang ◽

Yadan Liu ◽

...

Keyword(s):

Cell Therapy ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Efficacy Study ◽

T Cell Therapy ◽

Safety And Efficacy ◽

Car T Cell Therapy ◽

Car T ◽

Aggressive B Cell Lymphoma

Download Full-text

A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04182204 ◽

2019 ◽

Author(s):

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04250324 ◽

2020 ◽

Author(s):

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma

immuneACCESS ◽

10.21417/b7c301 ◽

2018 ◽

Author(s):

C Keane ◽

C Gould ◽

K Jones ◽

D Hamm ◽

D Talaulikar ◽

...

Keyword(s):

Tumor Microenvironment ◽

B Cell ◽

T Cell Receptor ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Cell Receptor ◽

Receptor Repertoire ◽

T Cell Receptor Repertoire ◽

Cell Receptor Repertoire ◽

Aggressive B Cell Lymphoma

Download Full-text

Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia

Genes Chromosomes and Cancer ◽

10.1002/gcc.20845 ◽

2011 ◽

pp. n/a-n/a ◽

Cited By ~ 4

Author(s):

Satoru Kobayashi ◽

Tomohiko Taki ◽

Yoshiaki Chinen ◽

Yasuhiko Tsutsumi ◽

Muneo Ohshiro ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

Chromosomal Rearrangements ◽

B Cell Lymphoma ◽

Fusion Transcripts ◽

Aggressive B Cell Lymphoma

Download Full-text

Adenoviral Subacute Focal Meningoencephalitis Complicating Polatuzumab, Bendamustine and Rituximab Chemo-Immunotherapy for Aggressive B-Cell Lymphoma

Indian Journal of Hematology and Blood Transfusion ◽

10.1007/s12288-021-01456-3 ◽

2021 ◽

Author(s):

Gurvin Chander ◽

Emmanouil Nikolousis ◽

Husam Osman ◽

Ellen Shirley ◽

Bhuvan Kishore ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Aggressive B Cell Lymphoma

Download Full-text

Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with MYC and MYC/BCL2 rearrangements, especially in germinal center cell-type tumors

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1927020 ◽

2021 ◽

pp. 1-4

Author(s):

Jennifer Chapman ◽

Ramiro E. Verdun ◽

Izidore S. Lossos

Keyword(s):

B Cell ◽

Germinal Center ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Cell Type ◽

Lim Domain ◽

Center Cell ◽

Aggressive B Cell Lymphoma

Download Full-text

Interleukin-8 Serum Levels - a Surrogate Marker for Pseudo-Tumor Progression Post Anti-CD19 Chimeric Antigen Receptor T Cells Treatment in Aggressive B-Cell Lymphoma

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00252-9 ◽

2021 ◽

Vol 27 (3) ◽

pp. S204-S206

Author(s):

Ivetta Danylesko ◽

Noga Shem-Tov ◽

Ronit Yerushalmi ◽

Avichai Shimoni ◽

Tima Davidson ◽

...

Keyword(s):

T Cells ◽

B Cell ◽

Tumor Progression ◽

Chimeric Antigen Receptor ◽

Cell Lymphoma ◽

Surrogate Marker ◽

B Cell Lymphoma ◽

Serum Levels ◽

Interleukin 8 ◽

Aggressive B Cell Lymphoma

Download Full-text

Bulky Aggressive B-Cell Lymphoma: To Radiate or Not to Radiate—That Is the Question

Journal of Clinical Oncology ◽

10.1200/jco.2013.54.1730 ◽

2014 ◽

Vol 32 (11) ◽

pp. 1097-1098 ◽

Cited By ~ 3

Author(s):

Brad S. Kahl

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Aggressive B Cell Lymphoma

Download Full-text